Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer

Michael J Zelefsky,Attapol Pinitpatcharalert,Marisa Kollmeier,Debra A Goldman,Sean McBride,Daniel Gorovets,Zhigang Zhang,Melissa Varghese,Laura Happersett,Neelam Tyagi,Margie Hunt

European Urology Oncology（2020）

引用 37|浏览33

暂无评分

摘要

Favorable tumor control rates were achieved in patients with low- and intermediate-risk prostate cancer treated with stereotactic body radiotherapy. Treatments were well tolerated without significant urinary or rectal side effects.

查看译文

关键词

Prostate cancer,Stereotactic body radiotherapy,Toxicity,Biopsy,Prostate-specific antigen,Rectal spacer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要